全文获取类型
收费全文 | 5738篇 |
免费 | 596篇 |
国内免费 | 1217篇 |
出版年
2024年 | 11篇 |
2023年 | 66篇 |
2022年 | 116篇 |
2021年 | 269篇 |
2020年 | 231篇 |
2019年 | 276篇 |
2018年 | 241篇 |
2017年 | 192篇 |
2016年 | 283篇 |
2015年 | 387篇 |
2014年 | 498篇 |
2013年 | 500篇 |
2012年 | 630篇 |
2011年 | 525篇 |
2010年 | 391篇 |
2009年 | 373篇 |
2008年 | 420篇 |
2007年 | 422篇 |
2006年 | 324篇 |
2005年 | 274篇 |
2004年 | 231篇 |
2003年 | 198篇 |
2002年 | 173篇 |
2001年 | 82篇 |
2000年 | 71篇 |
1999年 | 92篇 |
1998年 | 64篇 |
1997年 | 30篇 |
1996年 | 34篇 |
1995年 | 23篇 |
1994年 | 24篇 |
1993年 | 17篇 |
1992年 | 18篇 |
1991年 | 12篇 |
1990年 | 6篇 |
1989年 | 4篇 |
1988年 | 4篇 |
1987年 | 5篇 |
1986年 | 6篇 |
1985年 | 3篇 |
1984年 | 4篇 |
1983年 | 3篇 |
1982年 | 2篇 |
1980年 | 2篇 |
1972年 | 2篇 |
1970年 | 1篇 |
1967年 | 1篇 |
1963年 | 1篇 |
1959年 | 1篇 |
1950年 | 3篇 |
排序方式: 共有7551条查询结果,搜索用时 359 毫秒
51.
Kai Xiao Jun Tan Jian Yuan Gang Peng Wenyong Long Jun Su Yao Xiao Qun Xiao Changwu Wu Chaoying Qin Lili Hu Kaili Liu Shunlian Liu Hao Zhou Yichong Ning Xiaofeng Ding Qing Liu 《Journal of cellular and molecular medicine》2020,24(22):13235
Glioblastoma (GBM) is a malignant intracranial tumour with the highest proportion and lethality. It is characterized by invasiveness and heterogeneity. However, the currently available therapies are not curative. As an essential environmental cue that maintains glioma stem cells, hypoxia is considered the cause of tumour resistance to chemotherapy and radiation. Growing evidence shows that immunotherapy focusing on the tumour microenvironment is an effective treatment for GBM; however, the current clinicopathological features cannot predict the response to immunotherapy and provide accurate guidance for immunotherapy. Based on the ESTIMATE algorithm, GBM cases of The Cancer Genome Atlas (TCGA) data set were classified into high‐ and low‐immune/stromal score groups, and a four‐gene tumour environment‐related model was constructed. This model exhibited good efficiency at forecasting short‐ and long‐term prognosis and could also act as an independent prognostic biomarker. Additionally, this model and four of its genes (CLECL5A, SERPING1, CHI3L1 and C1R) were found to be associated with immune cell infiltration, and further study demonstrated that these four genes might drive the hypoxic phenotype of perinecrotic GBM, which affects hypoxia‐induced glioma stemness. Therefore, these might be important candidates for immunotherapy of GBM and deserve further exploration. 相似文献
52.
Qiuyue Li Hailing Yang Wenxiang Wang Ning Li Xuemei Zou Yangxin Li Gang Fan Yi Zhang Tingting Kuang 《化学与生物多样性》2020,17(1)
Brassica rapa L., also called NIUMA, is used empirically in Tibetan medicine for its antioxidant, anti‐inflammatory and antiradiation activities. This study explored the hepatoprotective effects of B. rapa polysaccharides (BRPs) on acute liver injury induced by carbon tetrachloride (CCl4) in mice and the underlying mechanisms. Mice were treated with CCl4 after the oral administration of BRPs (55, 110 and 220 mg/kg) or bifendate (100 mg/kg) for 7 days. Blood and liver samples of mice were collected for analysis after 24 h. The ALP, ALT and AST levels and the biological activities of SOD, MDA and GSH?Px were measured. Histopathological changes in the liver were determined through hematoxylin and eosin staining. Moreover, TNF‐α, IL‐1β and IL‐6 expression levels were detected by commercial reagent kits. Finally, Western blot analysis was used to check the relative expression levels of caspase‐3, p‐JAK2 and p‐STAT3. The BRP pre‐treatment significantly decreased the enzymatic activities of ALT, ALP and AST in the serum, markedly increased the activities of SOD and GSH?Px in the liver and reduced the MDA concentration in the liver. BRPs alleviated hepatocyte injury and markedly inhibited the expression of TNF‐α, IL‐1β and IL‐6, also downregulating the CCl4‐induced hepatic tissue expression of caspase‐3. Furthermore, BRPs inhibited the JAK2/STAT3 signaling pathway in a dose‐dependent manner in the liver. This study demonstrated that BRPs exert hepatoprotective effect against the CCl4‐induced liver injury via modulating the apoptotic and inflammatory responses and downregulating the JAK2/STAT3 signaling pathway. Therefore, B. rapa could be considered a hepatoprotective medicine. 相似文献
53.
Yaoyi Xiong Lushun Yuan Jing Xiong Huimin Xu Yongwen Luo Gang Wang Lingao Ju Yu Xiao Xinghuan Wang 《Journal of cellular and molecular medicine》2020,24(3):2342-2355
The precision evaluation of prognosis is crucial for clinical treatment decision of bladder cancer (BCa). Therefore, establishing an effective prognostic model for BCa has significant clinical implications. We performed WGCNA and DEG screening to initially identify the candidate genes. The candidate genes were applied to construct a LASSO Cox regression analysis model. The effectiveness and accuracy of the prognostic model were tested by internal/external validation and pan‐cancer validation and time‐dependent ROC. Additionally, a nomogram based on the parameter selected from univariate and multivariate cox regression analysis was constructed. Eight genes were eventually screened out as progression‐related differentially expressed candidates in BCa. LASSO Cox regression analysis identified 3 genes to build up the outcome model in E‐MTAB‐4321 and the outcome model had good performance in predicting patient progress free survival of BCa patients in discovery and test set. Subsequently, another three datasets also have a good predictive value for BCa patients' OS and DFS. Time‐dependent ROC indicated an ideal predictive accuracy of the outcome model. Meanwhile, the nomogram showed a good performance and clinical utility. In addition, the prognostic model also exhibits good performance in pan‐cancer patients. Our outcome model was the first prognosis model for human bladder cancer progression prediction via integrative bioinformatics analysis, which may aid in clinical decision‐making. 相似文献
54.
55.
Dafei Chai Dong Qiu Zichun Zhang Shang Yuchen Shi Gang Wang Lin Fang Huizhong Li Hailong Li Hui Tian Junnian Zheng 《Journal of cellular and molecular medicine》2020,24(18):10744-10755
Conditionally replicative adenoviruses (CRAds) were promising approach for solid tumour treatment, but its oncolytic efficiency and toxicity are still not satisfactory for further clinical application. Here, we developed the CAIX promotor (CAIXpromotor)‐controlled CRAd armed with a tumour suppressor absent in melanoma 2 (AIM2) to enhance its oncolytic potency. The CAIXpromotor‐AIM2 adenoviruses (Ad‐CAIXpromotor‐AIM2) could efficiently express E1A and AIM2 in renal cancer cells. Compared with Ad‐CAIXpromotor, Ad‐CAIXpromotor‐AIM2 significantly inhibited cell proliferation and enhanced cell apoptosis and cell killing, thus resulting in the oncolytic efficiency in 786‐O cells or OSRC‐2 cells. To explore the therapeutic effect, various Ads were intratumourally injected into OSRC‐2‐xenograft mice. The tumour growth was remarkably inhibited in Ad‐CAIXpromotor‐AIM2‐treated group as demonstrated by reduced tumour volume and weight with a low toxicity. The inflammasome inhibitor YVAD‐CMK resulted in the reduction of anti‐tumour activity by Ad‐CAIXpromotor‐AIM2 in vitro or in vivo, suggesting that inflammasome activation response was required for the enhanced therapeutic efficiency. Furthermore, lung metastasis of renal cancer mice was also suppressed by Ad‐CAIXpromotor‐AIM2 treatment accompanied by the decreased tumour fossil in lung tissues. These results indicated that the tumour‐specific Ad‐CAIXpromotor‐AIM2 could be applied for human renal cancer therapy. The therapeutic strategy of AIM2‐based CRAds could be a potential and promising approach for the therapy of primary solid or metastasis tumours. 相似文献
56.
Yuanzhi Zhu Joshua Sokolowski Xiancheng Song Yanghua He Yi Mei Gang Wu 《Liver Transplantation》2020,10(11)
Carbon‐based heteroatom‐coordinated single‐atom catalysts (SACs) are promising candidates for energy‐related electrocatalysts because of their low‐cost, tunable catalytic activity/selectivity, and relatively homogeneous morphologies. Unique interactions between single metal sites and their surrounding coordination environments play a significant role in modulating the electronic structure of the metal centers, leading to unusual scaling relationships, new reaction mechanisms, and improved catalytic performance. This review summarizes recent advancements in engineering of the local coordination environment of SACs for improved electrocatalytic performance for several crucial energy‐convention electrochemical reactions: oxygen reduction reaction, hydrogen evolution reaction, oxygen evolution reaction, CO2 reduction reaction, and nitrogen reduction reaction. Various engineering strategies including heteroatom‐doping, changing the location of SACs on their support, introducing external ligands, and constructing dual metal sites are comprehensively discussed. The controllable synthetic methods and the activity enhancement mechanism of state‐of‐the‐art SACs are also highlighted. Recent achievements in the electronic modification of SACs will provide an understanding of the structure–activity relationship for the rational design of advanced electrocatalysts. 相似文献
57.
Bing‐Qing Xiong Xinwei Zhou Gui‐Liang Xu Yuzi Liu Likun Zhu Youcheng Hu Shou‐Yu Shen Yu‐Hao Hong Si‐Cheng Wan Xiao‐Chen Liu Xiang Liu Shengli Chen Ling Huang Shi‐Gang Sun Khalil Amine Fu‐Sheng Ke 《Liver Transplantation》2020,10(4)
Alloy materials such as Si and Ge are attractive as high‐capacity anodes for rechargeable batteries, but such anodes undergo severe capacity degradation during discharge–charge processes. Compared to the over‐emphasized efforts on the electrode structure design to mitigate the volume changes, understanding and engineering of the solid‐electrolyte interphase (SEI) are significantly lacking. This work demonstrates that modifying the surface of alloy‐based anode materials by building an ultraconformal layer of Sb can significantly enhance their structural and interfacial stability during cycling. Combined experimental and theoretical studies consistently reveal that the ultraconformal Sb layer is dynamically converted to Li3Sb during cycling, which can selectively adsorb and catalytically decompose electrolyte additives to form a robust, thin, and dense LiF‐dominated SEI, and simultaneously restrain the decomposition of electrolyte solvents. Hence, the Sb‐coated porous Ge electrode delivers much higher initial Coulombic efficiency of 85% and higher reversible capacity of 1046 mAh g?1 after 200 cycles at 500 mA g?1, compared to only 72% and 170 mAh g?1 for bare porous Ge. The present finding has indicated that tailoring surface structures of electrode materials is an appealing approach to construct a robust SEI and achieve long‐term cycling stability for alloy‐based anode materials. 相似文献
58.
59.
目的:探讨莫西沙星联合用药方案对耐多药肺结核(MDR-TB)患者血清游离氨基酸和免疫功能的影响。方法:选取2015年9月到2018年1月期间我院收治的90例MDR-TB患者,根据乱数表法将患者分为研究组(n=45)、对照组(n=45),其中对照组给予左氧氟沙星联合常规化疗治疗,研究组则给予莫西沙星联合常规化疗治疗,比较两组临床疗效、痰菌转阴率、病灶吸收率、空洞闭合率、血清游离氨基酸和免疫功能,记录两组治疗期间不良反应情况。结果:研究组治疗18个月后的临床总有效率为71.11%(32/45),高于对照组的46.67%(21/45)(P0.05)。研究组治疗18个月后痰菌转阴率、病灶吸收率、空洞闭合率均较对照组高(P0.05)。两组患者治疗18个月后CD4+、免疫球蛋白A(Ig A)、免疫球蛋白G(Ig G)均升高,CD8+降低(P0.05),研究组治疗18个月后CD4+、Ig A、Ig G高于对照组,而CD8+低于对照组(P0.05)。两组治疗18个月后缬氨酸、谷氨酸均升高,且研究组高于对照组(P0.05)。两组患者总不良反应发生率比较无明显差异(P0.05)。结论:莫西沙星联合常规化疗治疗MDR-TB的疗效确切,可有效改善患者血清游离氨基酸水平,提高机体免疫功能,同时不增加不良反应发生率。 相似文献
60.
目的:比较分析腹腔镜和开腹结肠癌根治术治疗老年局部进展期结肠癌的临床疗效和安全性及对患者免疫功能的影响。方法:根据随机数字表法,将64例老年局部进展期结肠癌患者随机分为腹腔镜组和开腹组,每组各32例,分别接受腹腔镜、开腹结肠癌根治术治疗。比较两组手术相关指标、手术前后免疫功能变化、术后近远期并发症的发生情况及预后。结果:与开腹组比较,腹腔镜组患者手术时间明显延长,而术中出血量、胃肠功能恢复时间则明显缩短(P<0.05)。两组淋巴结清扫数比较差异无统计学意义(P>0.05)。术后3个月,腹腔镜组CD4+、CD4+/CD8+比值均明显高于开腹组(P<0.05),且与术前比较差异均无统计学意义(P>0.05)。与开腹组比较,腹腔镜组患者术后切口感染的发生率明显降低(P<0.05),两组其他近期并发症如吻合口瘘、吻合口出血,远期并发症如黏连性肠梗阻、切口疝的发生率比较差异均无统计学意义(P>0.05)。腹腔镜组与开腹组术后2年的局部复发率、1年和2年生存率比较差异均无统计学意义(P>0.05)。结论:腹腔镜手术和开腹手术治疗老年局部进展期结肠癌患者的临床疗效和预后相当,但腹腔镜手术对患者的免疫功能影响更小,且安全性更高。 相似文献